Allico Pharma rises 5.3% amid rising trend in anthelmintics (fenbendazole, etc.) theme

On the 10th, the theme of anthelmintics (including fenbendazole) showed strength by rising 4.12% compared to the previous day, while Allico Pharmaceutical, which is gaining attention as a related stock, surged by 5.3% compared to the previous day. Allico Pharmaceutical is known as a pharmaceutical company developing generics and new natural product medicines.

[Graph] Major stock price changes in the anthelmintics (including fenbendazole) theme



According to preliminary data compiled at 10:15, foreign investors are net selling -5,900 shares of Allico Pharmaceutical.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)



According to the analysis by Thinkpool Robo Algorithm RASSI, Allico Pharmaceutical ranked first in quant financial ranking (out of 7 stocks) by exceeding the average scores of the theme in growth, stability, and profitability. This can be interpreted as Allico Pharmaceutical having a relatively high investment attractiveness compared to other stocks in the theme from a financial perspective.

[Table] Top stocks by financial scores within the theme


※ The quant financial score is the result of the robo algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.